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ABSTRACT 
 
Bone morphogenetic protein 4 (BMP4) plays an important role in mouse embryonic stem 
cells (ESCs) by sustaining pluripotency and blocking differentiation towards neural fate. In 
this study, we have analyzed the miRNAs regulated by BMP4 in ESCs. We have found 
that BMP4 signaling directly regulates miR-23a, miR-24-2 and miR-27a through the 
binding of phospo-Smads on the promoter of the gene encoding all these miRNAs. The 
suppression of miR-23a, miR-24-2 and miR-27a, together with the suppression of miRNAs 
of the same families, miR-23b, miR-24-1 and miR-27b, does not impair ESC stemness 
maintenance and epiblast stem cells (EpiSCs) derivation from ESCs. However, this 
suppression affects ESC differentiation, thus resulting in the increase of the number of 
cells undergoing apoptosis soon after the transition from ESCs to EpiSCs. We have 
demonstrated that the block of BMP4 signaling completely rescues the apoptosis induced 
by the suppression of miRNAs. Considering that it was already known that BMP4 induces 
apoptosis during ESC differentiation, our observation suggests that the apoptotic 
phenotype provoked by miRNA suppression is due to an enhancement of BMP4 signaling. 
We also demonstrated that miR-23a and miR-23b clusters target Smad5, a downstream 
effector of BMP4 pathway; this phenomenon explains how the suppression of miRNA 
clusters enhances BMP4 signaling. In conclusion, the results unveil the existence of a 
feedback loop, involving Smad5 and miR-23a clusters, that regulates the apoptosis induced 
by BMP4 during ESC neural differentiation.    
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INTRODUCTION 
 
Embryonic Stem cells and neural differentiation 
 
Mouse Embryonic Stem cells (ESCs) were firstly established in 1981 from the Inner Cell 
Mass (ICM) of the pre-implantation embryo at stage of early blastocyst. Early blastocyst is 
composed of a cluster of cells, the inner cell mass, placed to one side of the vesicle and of 
an epithelial outer layer, the trophectoderm, enclosing a fluid filled space (the blastocyst 
cavity). The ICM give rise to all cells of the embryo, while trophectoderm cells give rise to 
extraembryonic tissues, such as placenta, critical for supporting embryonic development. 
During the implantation of the blastocyst, the ICM gives rise to a new epithelial layer, the 
Primitive Endoderm. Later this epithelium also lines the luminal surface of the mural 
trophectoderm away from the ICM and contributes to the visceral and parietal endoderm. 
In addition to the Primitive endoderm, the ICM gives rise to the epiblast in the post-
implantation embryo, from which Primitive ectoderm derives (Rossant et al., 2003). 
Primitive ectoderm in turn give rise to all three embryonic germ layers (ectoderm, 
mesoderm and definitive endoderm) and primordial germ cells (Pfister et al., 2007) 
 
 
Figure 1. Pre-implantation mouse embryo development. 
Morula is formed at 2.5 days from egg fertilization. After cleavage division, compaction and 
cavitation of morula, blastocyst is formed at 3.5 days. It contains two type of cells: ICM cells that 
give rise to all cells of the embryo, and trophectoderm cells which give rise to trophoblast. At late 
blastocyst stage, the ICM is surrounded by a cell type known as primitive endoderm, that gives rise 
to the yolk sac to support embryonic development. In this stage, ICM cells are at Epiblast state. At 
early egg cylinder state, primitive endoderm differentiate toward visceral and parietal endoderm 
while Epiblast cells give rise to primitive ectoderm that can differentiate into all three embryonic 
germ layers. Adapted from: Huang et al., 2015.   
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All these steps of embryogenesis can be recapitulated by ESCs. In vitro ESCs proliferate 
indefinitely without differentiation, a property defined ‘‘self-renewal’’, and at the same 
time they retain the potential of generating cells of the three germ layers, termed 
‘‘pluripotency’’. Traditionally, ESC pluripotency has often been defined as the ability to 
generate all cell types of an embryo apart from the trophectoderm. This is because an 
earlier analysis of chimeric mouse embryos, produced by injection ESCs into blastocysts, 
had shown that these cells are excluded from the trophectoderm lineage (Beddington  et al., 
1989). However, it has subsequently been found that the ICM and ESCs do still possess the 
ability to differentiate into the trophectoderm lineage (Pierce et al., 1988; Niwa et al., 
2005). Therefore, ESC pluripotency is now defined as the ability to generate all cell types, 
including the trophectoderm, without the self-organizing ability to generate a whole 
organism (Niwa et al., 2007).  
These remarkable characteristics, self-renewal and pluripotency, made ESCs a powerful 
source of differentiated cells that could be used in cell replacement therapy. However, the 
use of ESC in cell replacement therapy remains a main goal in the field. So advances in our 
understanding of ESC differentiation are necessary to provide new insights for the 
generation of clinically relevant cell population for cell therapy.  
In order to obtain pure cell population to be used in cell therapy, in recent years many 
protocols have been developed to induce the differentiation of ESCs into cells of the three 
germ layers, in particular great efforts were made to obtain neural precursors cells (NPCs) 
from ESCs, with the idea to use these cells in the treatment of neurodegenerative diseases. 
The removal of LIF from the conventional serum-free culture medium, with N2 and B27 
supplements, is the simplest strategy to obtain neural differentiation of ESCs. Moreover, 
the addition of fibroblast growth factor (FGF) in this differentiation protocol allows the 
emergence of cells in the rosette conformations typical of neuroepithelial cells (Ying et al., 
2003b). Another method is based on the formation of Embryoid bodies (EB): a defined 
numbers of ESCs are cultured in nonadhesive condition in absence of LIF and Retinoic 
acid is added in the last 4 days of differentiation (Bibel et al., 2004). The presence of 
retinoic acid increases the percentage of neural cells in the EB, but evokes caudalization, 
so inhibits the production of the cells of the rostral central nervous system (Wichterle et al., 
2002; Mizuseki et al., 2003). To avoid the use of retinoic acid and growth factors, 
Watanabe and collaborators have developed a new differentiation method based on the 
formation of Serum Free Embryoid bodies (SFEBs). They cultured ESCs in suspension 
culture conditions without LIF and serum, but in presence of a medium containing Knock-
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out Serum Replacement (KSR) that supports the growth of ESC aggregate. In these 
conditions they obtained a large number of neural precursor and, unlike embryoid bodies 
cultured in a serum-containing medium, they generated neural precursors without the 
concomitant induction of mesodermal and endodermal precursors  (Watanabe et al., 2005).  
 
 
 
Figure 2. Main neural differentiation protocols 
ESCs can be induced to differentiate into neural precursors by using different protocols. The first 
method is based on the culture of ESCs on gelatin coated dishes in absence of LIF and in the 
presence of serum-free culture medium with N2 and B27 supplements. The second method consists 
in plating ESCs at low density in nonadhesive condition and in absence of LIF. In this way, 
Embryoid bodies are formed and, after 4 days, the addition of Retinoic acid improves neural 
differentiation. The third method is based on the formation of Serum Free Embryoid bodies 
(SFEBs). ESCs are plated at low density in nonadhesive condition in serum-free medium without 
LIF and in presence of KSR.  
 
Using SFEB differentiation method, Zhang and co-workers have demonstrated that neural 
differentiation occurs in two steps: by the transition from ESCs to Epiblast Stem cells 
(EpiSCs) and then from EpiSCs to neuroectoderm precursors. They have demonstrated that 
SFEBs at 2 days of differentiation are comparable to cells of the egg cylinder stage 
epiblast, therefore SFEB differentiation recapitulates the differentiation steps taking place 
in vivo from ICM to neuroectoderm formation (Zhang et al., 2010).  
EpiSCs can be isolated from the egg cylinder epiblast, moreover, in particular culture 
conditions, EpiSCs can be also derived from ESCs and maintained in culture by adding 
activin and Fgf2. Cells obtained in this way have the same characteristics of EpiSCs 
derived from mouse embryos and express the canonical EpiSC gene Fgf5 (Brons et al., 
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2007; Tesar et al., 2007). EpiSCs as well as ESCs can differentiate into precursors of the 
three germ layers depending on the activity of specific signaling pathways.  
 
 
 
Figure 3. ESC self-renewal and differentiation  
Thanks to the ability to self-renew, ESCs can be maintained in vitro indefinitely, whereas thanks to 
pluripotency these cells can differentiate into cells of all the three germ layers (ectoderm, 
mesoderm and endoderm), passing through the Epiblast state. Upon proper stimuli, ESCs can 
differentiate into skin and neural precursors from ectoderm germ layer, or into mesoderm cells, like 
hematopoietic, vascular and cardiac cells, or into hepatocyte and pancreatic cells from endoderm 
germ layer.  
Adapted from: Murry et al., 2008  
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Signaling transduction pathways  
ESC self-renewal and differentiation are regulated by specific extracellular signals. A key 
regulator of ESC self-renewal is the leukaemia inhibitory factor (LIF) (Smith et al., 1988). 
LIF is a member of the IL-6 cytokine family, it binds the LIF receptor (LIFR) which works 
as a heterodimer together with gp130 receptor and activates Janus-associated tyrosine 
kinase (JAK) and signal transducer and activation of transcription-3 (STAT3). The ability 
of LIF to sustain the ESC self-renewal depends on the activation of STAT3 (Niwa et al., 
1998), whose activation is sufficient to prevent ESCs differentiation in the presence of 
serum (Matsuda et al., 1999). Moreover, LIF stimulates the activation of the mitogen-
activated protein kinase (MAPK), which induce pro-differentiative signals (Burdon et al., 
1999). Therefore LIF sustains self-renewal and prevents ESC differentiation balancing 
STAT3 and MAPK activation.  
However, LIF is necessary but not sufficient to maintain ESCs in the undifferentiated state 
in serum-free medium, indicating that there are many factors in serum required to sustain 
self-renewal and prevent differentiation. One of the most important of these serum factors 
is Bone Morphogenetic Protein 4 (BMP4). It belongs to the Transforming growth factor 
(TGF-β) superfamily that includes also TGF-β, Activin, Nodal and other related proteins. 
These proteins play an important role in the establishment of body plan and tissue 
differentiation through their effect on cell proliferation, differentiation and migration 
(Derynck et al., 2003).  
TGF-β signaling pathways are induced by heterodimerization of type I and type II 
receptors upon ligand binding. The phosphorylation of type I receptor by type II receptor 
allows the recruitment and the phosphorylation of receptor-regulated SMAD proteins (R-
SMADs). SMAD 1,5 and 8 are activated by the binding of BMP4 to type I receptors Alk 
1,2,3 and 6, whereas SMAD 2,3 are activated by the binding of Nodal/Activin to type I 
receptors Alk 4,5 and 7. Activated R-SMADs in turn form complexes with the common 
mediator SMAD4. SMAD complexes accumulate in the nucleus, where they are directly 
involved in regulating the transcription of target genes (Schmierer et al., 2007). The main 
BMP4 target genes involved in the maintenance of ESC self renewal are the helix-loop-
helix Ids (inhibitors of differentiation). Ids functionally antagonize neurogenic bHLH 
transcription factors and block the neural differentiation (Gerrard et al., 2005). Exogenous 
expression of Ids mimic the effect of BMP4 in mouse ESCs (Ying et al., 2003a). The 
induction of Id genes by BMP4 has been reported also in differentiating ESC cultures 
(Hollnagel et al., 1999) and is dependent by BMP pathway but not by LIF. An interaction 
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between BMP4 and LIF has been found by Ying and collaborators (Ying et al., 2003a). 
Indeed, they have demonstrated that activated STAT3 and Smad1 may colocalize, 
supporting the hypothesis that BMP4/Smad1 sustains LIF/STAT3 function in mouse ES 
cells (Ying et al., 2003a). Interestingly, BMP4 sustains self-renewal also through inhibition 
of ERK by up-regulating Dual-specificity phosphatase 9 (DUSP9) gene that in turn inhibits 
phosphorlation of ERK (Qi et al., 2004; Li et al., 2012).  
As already mentioned, BMP4 signaling has crucial functions in maintaining pluripotency 
of mouse ESCs but it has also a crucial role in the inhibition of neural differentiation 
(Kawasaki et al., 2000; Tropepe et al., 2001; Ying et al., 2003a). Very interestingly, Zhang 
and collaborators suggested that there is a BMP4-sensitive window during ESC neural 
differentiation (Zhang et al., 2010). They observed that BMP4 suppresses neural 
differentiation, but once neural commitment is initiated, BMP4 is no longer able to inhibit 
it. Indeed, in the first stage of ESC differentiation, BMP4 inhibits EpiSC derivation, 
whereas in the later stages, when the commitment of EpiSCs into precursors of the three 
germ layers occurs, BMP4 suppresses neural differentiation ad promotes mesoderm and 
endoderm commitment (Zhang et al., 2010). In addition, the effects of BMP4 on ESC 
differentiation are dose-dependent; high doses of BMP4 block differentiation and maintain 
pluripotency, while low doses of BMP4 induce apoptosis of neural precursor cells during 
epidermal differentiation of ESCs (Gambaro et al., 2006), through the activation of 
Caspase-3  
 
10 
 
 
 
Figure 4. BMP4 and LIF signalin pathways in ESC self-renewal and differentiation 
BMP4 ligand binds Alk3/6 receptor that heterodimerizes with type II receptor BMPRII, resulting in 
the activation of Smad1,5,8 proteins. These proteins form a complex with Smad4 that traslocates 
into the nucleus. Smad complex induces the transcription of Id1/2/3 and Dusp9 genes which inhibit 
neuroectoderm differentiation. On the other hand, LIF activates JAK1/STAT3, by sustaining self-
renewal and inhibiting mesoderm and endoderm differentaiton of ESCs. 
Taken from Huang et al., 2015. 
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Transcriptional factors regulating ESC pluripotency  
 
ESCs require extrinsic growth factors for the maintenance of pluripotency in culture. These 
extrinsic stimuli converge in a network of key transcription factors that controls 
pluripotency. This network includes the homeodomain transcription factor Oct3/4 (Niwa et 
al., 2000), the high mobility group (HMG)–box transcription factor Sox2 (Avilion et al., 
2003) and the variant homeodomain transcription factor Nanog (Chambers et al., 2003). 
Oct3/4 is a POU domain-containing transcription factor that is expressed in pluripotent 
cells during mouse embryogenesis, both ESCs and EpiSCs, even if its expression is weaker 
in EpiSCs. ESCs during differentiation lose the expression of Oct3/4, indeed this protein is 
tightly related to pluripotency. The loss of Oct3/4 induces inappropriate trophectoderm 
differentiation because it interacts with Cdx2 (a trigger for trophectoderm differentiation) 
to form a repressor complex. This complex interferes with the autoregulation of these two 
factors, giving rise to a reciprocal inhibition system that establishes their mutually 
exclusive expression (Niwa et al., 2005). ESC-specific enhancers containing binding sites 
for Oct3/4 and Sox2 have been identified in genes such as Nanog (Boyer et al., 2005; 
Kuroda et al., 2005; Rodda et al., 2005), Rex1 (Shi et al., 2006) and in Oct3/4 and Sox2 
themselves, suggesting that these two transcription factors are regulated by a positive-
feedback loop (Chew et al., 2005).  
Another transcription factor having an essential role in maintaining the pluripotent state of 
the ICM and ESCs is Nanog. It is a homeobox-containing transcription factor expressed in 
pluripotent cells and absent in differentiated cells. The mechanism through which Nanog 
regulates stem cell pluripotency is unclear. Based on the differences in gene expression 
between wild-type and Nanog null cells, it has been proposed that Nanog regulates 
pluripotency mainly as a transcription repressor for downstream genes that are important 
for cell differentiation such as Gata4 and Gata6 (Chambers et al., 2003; Mitsui et al., 
2003). However, Nanog can also activate the genes necessary for self-renewal such as 
Rex1 and Oct3/4 (Pan et al., 2006). Nanog disruption in ESCs not only results in the 
differentiation into primitive endoderm (Liu et al., 2007), but also blocks neuronal 
differentiation induced by the removal of LIF and BMPs from serum-free culture (Ying et 
al., 2003b). In addition, Nanog can also block mesoderm specification by repressing 
brachyury, which encodes the mesoderm-specific T-box transcription factor T. Thus, 
Nanog can block primitive endodermal differentiation, neuronal differentiation and 
mesodermal differentiation under different culture conditions. 
12 
 
These results suggest the crucial role of transcriptional factors in ESC pluripotency and 
differentiation. However in recent years also post-transcriptional gene regulation by 
microRNAs (miRNAs) is emerging as an essential regulator of ESC development (Cheng 
et al., 2005). 
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miRNAs regulating ESC pluripotency and neural differentiation 
 
miRNAs are fine-tuning regulators of gene expression and are involved in a wide spectrum 
of biological processes including cell proliferation (Delaloy et al., 2010; Niu et al., 2013), 
cell fate determination and differentiation (Bartel et al., 2004; Chen et al., 2004; Makeyev 
et al., 2007; Li et al., 2010; Akerblom et al., 2013). 
microRNAs are 20–25 nucleotide non-coding RNAs that bind to the 3' untranslated region 
(UTR) of target mRNAs resulting in mRNA degradation or block of translation (Rana 
2007). miRNAs are transcribed by RNA polymerases II and III (Bartel et al., 2004; 
Rodriguez et al., 2004) as precursor transcripts, called primary microRNAs (pri-miRNAs). 
Some miRNAs are organized in polycystronic clusters and they are transcribed as a unique 
pri-miRNA (miRNA cluster). These miRNAs often belong to different miRNA family, so 
they do not target the same mRNA. Pri-miRNAs are processed in the nucleus into an 
intermediate form (pre-miRNAs) by Drosha and DiGeorge syndrome critical region gene 8 
(DGCR8; also known as Pasha) proteins. Pre-miRNAs can also be generated by a non-
canonical mirtron pathway. mirtrons are miRNAs located in the introns of a protein coding 
gene (Okamura et al., 2007; Westholm et al., 2011). When the host gene is transcribed, 
spliceosome and debranching enzyme produce a pre-miRNA that is ready to be processed. 
Pre-miRNAs obtained from canonical and non-canonical pathways are translocated by the 
exportin5 into the cytoplasm, in which they are further processed by Dicer, an RNase III-
like enzyme, into mature miRNAs (Gangaraju and Lin 2009). miRNAs are recognized by 
RNA-induced silencing complex (RISC), containing an Argonaute family member, that 
drives repression of mRNA translation and stability.  
Thanks to their function in translational attenuation, miRNAs are considered fine 
regulators of gene expression. Their crucial function in ESCs has been demonstrated by 
analyzing the phenotypes of DGCR8 and Dicer mutants. In particular, Dicer knock-out 
ESCs are not able to properly differentiate and exhibit slow proliferation rate 
(Kanellopoulou et al. 2005), whereas DGCR8 null cells show affected differentiation, 
proliferation and cell cycle progressing (Wang et al., 2007). ESC specific miRNAs have 
been identified comparing the expression of miRNAs in ESCs and in differentiated cells. 
With this approach the miR-290 family has been found to be expressed specifically in 
undifferentated cells (Houbaviy et al., 2003). This miRNA family is involved in cell cycle 
regulation and prevents the epigenetic silencing of pluripotent factors Oct3/4, Sox2, Nanog 
and Myc targeting repressor of de novo DNA methyltransferase (DNMT) (Sinkkonen et 
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al., 2008). Oct3/4, Sox2 and Nanog in turn recognize the predicted promoter region of 
miR-290 cluster, regulating the expression of these miRNAs in ESCs (Marson et al., 
2008). These data indicate that a tight control of miRNA expression is required to maintain 
stemness.  
Interestingly, there are also miRNAs regulating ESC differentiation. Of note, Tarantino 
and co-workers have found 138 miRNAs  up-regulated during ESC differentiation. Among 
these miRNAs, they found that miR-34a, miR-100, and miR-137, are required for the 
proper differentiation of ESCs by regulating Sirt1, Smarca5, and Jarid1b genes which are 
involved in sustaining the undifferentiated state (Tarantino et al., 2010). In addition, 
several miRNAs have been characterized for their function in the first stages of 
neurogenesis. In particular, miR-134 is an inducer of ESC differentiation (Gaughwin et al., 
2011). It is not expressed in undifferentiated cells but its expression increases in ESCs 
treated with retinoic acid. It induces differentiation into ectodermal lineages targeting Sox2 
and Nanog and regulating indirectly Oct3/4 in combination with miR-296 and miR-470 
(Tay et al., 2008; Niu et al., 2013). Moreover, depending on the stage of neural 
differentiation, miR-134 has also other effects and targets. Indeed it enhances neural 
precursors proliferation and counteracts their apoptosis and differentiation (Gaughwin et 
al., 2011). Another crucial miRNA involved in ESC differentiation, self-renewal and 
pluripotency is let-7 (Melton et al., 2010). Let-7a miRNA is highly expressed in somatic 
cells, while pri-let-7 immature transcripts are present at high levels in ESCs. In these cells 
the processing of immature pri-let-7 into mature let-7 is inhibited by binding of Lin28 that 
blocks Drosha and Dicer action (Newman et al., 2008; Heo et al., 2008). Let-7a in turn 
induce neural commitment of ESCs by targeting Lin-28 (Rybak et al., 2008). In addition, 
the inhibition of another miRNA belonging to the let-7 family, let-7b, induces proliferation 
of neural stem cells (NSCs) and blocks their neuronal differentiation (Zhao et al., 2010). 
Also some brain-specific miRNAs, such as miR-124a and miR-9, are involved in the 
neural differentiation of ESCs (Krichevsky et al., 2006). Krichevsky and collaborators 
found that miR-124a and miR-9 prevent the activation of STAT3, a protein that inhibits 
neuronal differentiation, thus inducing neural lineage commitment (Krichevsky et al., 
2006) . Moreover Saunders and co-worker demonstrated that miR-9, together with miR-
181a and b, miR-204, miR-199b and miR-135a, prevent SIRT1 expression during neuronal 
differentiation (Saunders et al., 2010). We have recently found that another miRNA is 
involved in a feedback loop regulating ESC differentiation: miR-125a. In particular, we 
uncovered that BMP4 directly up-regulates miR-125a, that, in turn, targets a co-receptor of 
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BMP4 receptor, Dies1. Its suppression results in a reduced sensibility of ESCs to BMP4 
and in an unbalance of BMP4 and Nodal/Activin pathways in favor of the latter. The 
resulted up-regulation of Nodal/Activin pathway blocks ESC differentiation maintaining 
cells in the epiblast state, demonstrating that this feedback loop is required for the proper 
differentiation of ESCs (Parisi et al., 2012). Thus, our findings suggest that this miR-125-
dependent loop sets the sensitivity of ESCs to BMP4. In addition, we have found that miR-
125b, another member of miR-125 family, also targets Dies1, down-regulating BMP4 
signal transduction. Interestingly, we have found that unlike miR-125a, miR-125b is not 
directly regulated by TGFβ signals, suggesting that miRNAs having the same function 
could be regulated in independent manners to fine tuning the response of the cells to 
extracellular cytokines (Battista et al., 2013). In conclusion, these findings suggest that the 
study of miRNAs regulated by BMP4 is crucial to better understand the molecular 
mechanisms involved in ESC differentiation.  
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Figure 5. Biogenesis and regulatory features of the microRNAs 
microRNA genes are transcribed as primary miRNA transcripts. These are processed into pre-
microRNAs in the nucleus by a Microprocessor complex, which contains the RNase III enzyme 
Drosha and the double-stranded RNA-binding protein DiGeorge syndrome critical region gene 8 
(DGCR8). Pre-microRNAs are then transported by exportin 5, which is a karyopherin, and 
RanGTP into the cytoplasm, where they are further processed by the RNAse III enzyme Dicer and 
by the double-stranded RNA-binding protein TRBP (TAR (HIV) RNA binding protein 2). This 
results in double-stranded 20–25 nucleotide (nt) intermediates with 2 nt overhangs on the 3' end. 
One of the RNA strands is then loaded by Dicer into an RNA-induced silencing complex (RISC), 
which contains an Argonaute-subfamily member, that then targets the 3' untranslated region of the 
target mRNAs. An imperfect match between the microRNA and the mRNA results in translational 
repression, whereas a perfect match between the microRNA and the mRNA results in degradation 
of mRNA targets. Taken from Lodish et al., 2008.  
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RESULTS 
 
miRNAs expression profile in ESCs upon BMP4 treatment  
In order to identify the miRNAs regulated by BMP4 and involved in neural differentiation 
of ESCs, we performed a miRNA expression profile in ESCs treated with BMP4 in a 
chemical defined medium (KSR) without serum and in the presence of LIF. Of note, the 
absence of serum avoids the influence of growth factors and switchs off TGFβ signaling. 
To verify the activation of BMP4 signaling upon BMP4 treatment, we measured the levels 
of Smad phosphorylation and Smad target genes, Id1 and Id3, after 1h of BMP4 treatment. 
As shown in figure 6, BMP4 treatment induces a strong phosphorylation of Smad1/5/8 and 
significantly enhances the transcription of Id1 and Id3 genes (Figure 6a). Moreover, we 
measured the accumulation of miR-125a, a miRNA directly regulated by BMP4 (Parisi et 
al., 2012),  after 24h of BMP4 treatment, and we found increased levels of mature miR-
125a, as expected (Figure 6b).  
 
Figure 6. BMP4 treatment activates BMP4 signaling pathway and miR-125a transcription.  
a) ESCs were cultured overnight in serum free medium with KSR and LIF and treated with 
20ng/ml of BMP4 for 1 hour. Smads protein levels were analyzed by western blotting (left panel), 
Ids expression levels were analyzed by qPCR (right panel). b) ESCs were cultured overnight with 
KSR and LIF and treated with 20ng/ml of BMP4 for 24 hours. Accumulation of mature miRNA 
was analyzed by qPCR. Data are reported as fold change relative to untreated (-BMP4) ESCs (fold 
change = 1). Numbers over the bars indicate the P-Value. 
 
To perform miRNA expression profile we used two miRNA qPCR panels containing 384 
pairs of dried down LNA primer sets for the detection of each miRNA annotated in the 
Sanger miRBase version 17 database. This procedure provided exceptional sensitivity 
enabling accurate quantification of very low microRNA levels and a single-base 
discrimination among very similar microRNAs. We measured the levels of miRNAs in 
ESCs treated or not with BMP4 for 24h, when processing of all pri-miRNAs is completed 
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and we selected miRNAs on the basis of Standard Error (S.E.) and fold change. The results 
of miRNA expression profile allowed us to cluster microRNAs in two groups: miRNAs 
up-regulated and down-regulated by BMP4 (Table 1). As expected, we found miR-125a 
among up-regulated miRNAs, in agreement with our previous observation (Parisi et al., 
2012). 
Up-regulated miRNAs Down-regulated miRNAs 
mmu-miR-125a mmu-miR-10a 
mmu-miR-142 mmu-miR-135a 
mmu-miR-187 mmu-miR-139 
mmu-miR-193b mmu-miR-141 
mmu-miR-196a mmu-miR-153 
mmu-miR-199a mmu-miR-181b 
mmu-miR-211 mmu-miR-1937b 
mmu-miR-23a mmu-miR-20b 
mmu-miR-24 mmu-miR-217 
mmu-miR-27a mmu-miR-219 
mmu-miR-27b mmu-miR-30a 
mmu-miR-29b mmu-miR-363 
mmu-miR-302d mmu-miR-369 
mmu-miR-324 mmu-miR-375 
mmu-miR-339 mmu-miR-431 
mmu-miR-362 mmu-miR-449a 
mmu-miR-379 mmu-miR-449c 
mmu-miR-503 mmu-miR-466d 
mmu-miR-582 mmu-miR-496 
mmu-miR-9 mmu-miR-673 
 
mmu-miR-674 
 
mmu-miR-677 
 
mmu-miR-770 
 
mmu-miR-7a 
 
mmu-miR-7b 
 
mmu-miR-99a 
 
Table 1. miRNAs up- and down-regulated by BMP4 
ESCs were treated with BMP4 for 24h and then all mature miRNAs annotated in the Sanger 
miRBase version 17 database were measured using miRNA qPCR panels. Data are presented as 
fold change over miRNA levels in control untreated samples. miRNAs were classified as up-
regulated and down-regulated upon BMP4 treatment using as cut-off >1.25- and <0.75- fold 
change, respectively.  
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miR-23a, miR-24-2 and miR-27a are regulated by BMP4 
In order to understand whether up- and down-regulated miRNAs are directly regulated by 
BMP4, we measured the levels of their primary transcripts (pri-miRNAs) upon 1h of 
BMP4 treatment. Indeed, after 1h of BMP4 treatment, direct targets of BMP4 are already 
transcribed. Using real time PCR procedure, we found increased levels of miR-23a, miR-
24-2, miR-27a as well as miR-125a transcripts (Figure 7). 
 
Figure 7. Primary transcripts of up-regulated miRNAs. 
ESCs were treated with BMP4 for 1h and pri-miRNA transcript levels were measured by qPCR. 
Data are shown as fold change over the level of miR-125a in untreated (-BMP4) ESCs (fold change 
= 1). Numbers over the bars indicate the P-Value. 
 
Of note, miR-23a, miR-24-2 and miR-27a derive from a unique miRNA cluster gene, miR-
23a cluster, located on chromosome 8. These miRNAs belong to different families, 
therefore they do not share the seed sequence and, as a consequence, do not target the same 
mRNAs. To confirm that the induction of these three miRNAs by BMP4 treatment results 
in the accumulation of the mature form, we measured levels of miRNAs by Q-PCR 
analysis with specific LNA probes. As shown in Figure 8a, we found a significant increase 
of mature miR-23a, miR-24-2 and miR-27a upon 24h of BMP4 treatment. Moreover, to 
better characterize the expression regulation of miR-23a cluster we inhibited BMP4 
signaling. Indeed, if BMP4 directly regulates miR-23a cluster, the block of BMP4 
signaling should reduce the expression of these miRNAs. Thus, we treated ESCs with the 
BMP4 antagonist Dorsomorphin to block BMP4 signaling. Alternatively, we silenced 
BMP4 effectors Smad1 and Smad5 by RNA interference. In both cases we found a marked 
decrease of the primary transcript of miR-23a cluster (Figure 8b-d).  
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Figure 8. BMP4 regulates miR-23a, miR-24-2 and miR-27a. 
a) Undifferentiated cells were treated with BMP4 and after 24h miRNA levels were measured by 
qPCR. b) ESCs were treated with Dorsomorphin for 1h and Id1 mRNA levels and pri-miRNA of 
miR-23a cluster were measured by qPCR . c) Silencing of Smad1 and Smad5 was evaluated after 
24h of siRNA transfection by qPCR. d) ESCs were transfected with the indicated siRNAs and after 
24h pri-miR-23a cluster levels were evaluated by qPCR. Data are presented as fold change relative 
to control (-BMP4, DMSO, siCtrl) ESCs (fold change = 1). Numbers over the bars indicate the P-
Value. 
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BMP4 regulates miR-23a cluster at transcriptional level  
To understand whether miR-23a cluster is regulated by BMP4 at transcriptional level, we 
searched for Smad binding sites on the promoter of miR-23a cluster gene by using 
Chromatin Immunoprecipitation (ChIP). In particular, we treated ESCs with BMP4 for 1h 
and then we immunoprecipitated chromatin with phospho-Smad1/5/8 antibody and we 
found activated Smads bound to Id1 promoter, as expected (Ying et al., 2003a) (Figure 9a). 
At the same time, we searched for Smad binding sites in the region of 10 kb upstream of 
the transcriptional start site of miR-23a cluster gene. We found significant enrichments in 
the chromatin immunoprecipitated with anti-Smads antibody in five regions upstream of 
miR-23a cluster gene, demonstrating that miR-23a cluster is regulated at transcriptional 
level by BMP4 (Figure 9b). In agreement with these results, sequence analysis of upstream 
region of miR-23a cluster revealed many consensus binding sites for Smads (Fei et al., 
2010). 
 
 
Figure 9. Phospho-Smads bind genomic upstream region of miR-23a cluster. 
a) ESCs were treated with BMP4 for 1h and ChIP assay was performed using anti-phospho-
Smad1/5/8 antibody. Id1 immunoprecipitation was evaluated by ChIP-qPCR. Data are expressed as 
fold enrichment relative to the IgG controls (fold change = 1). b) Undifferentiated cells were 
treated with BMP4 for 1h and the binding of phospho-Smad1/5/8 was evaluated by ChIP assay. 
DNA was immunoprecipitated with anti-phospho-Smad1/5/8 antibody and specific primer 
(indicated by arrows on the top of the panel) were used to amplify regions upstream to the 
transcriptional start site of miR-23a cluster. Data are shown as fold change over untreated (-BMP4) 
ESCs (fold change = 1). Numbers over the bars indicate the P-Value.  
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miR-23a and miR-23b clusters are expressed in ESCs and during neural 
differentiation 
In the study of miR-23a cluster functions, we first wondered whether miR-23a, miR-24-2 
and miR-27a are expressed in ESCs and during neural differentiation. We induced neural 
differentiation through the formation of serum-free embryoid bodies (SFEBs), that results 
in the generation of epiblast stem cells (EpiSCs) before day 2, and then differentiate into 
neuroectodermal precursors. We measured the levels of miR-23a, miR-24-2 and miR-27a 
in undifferentiated cells and during SFEB differentiation, and we found that they are 
expressed in ESCs and their expression decreases during differentiation, even if it is still 
significant at 4 days of SFEB differentiation (Figure 10a). Another miRNA cluster, named 
miR-23b cluster, is located on chromosome 13 and it encodes for miR-23b, miR-24-1 and 
miR-27b. miR-24-1 is identical to miR-24-2, whereas miR-23a and miR-27a belong to the 
same families of miR-23b and miR-27b, respectively. Since miRNAs of the same families 
share the same targets, we also investigated the expression of miR-23b cluster, and we 
found that this miRNA transcript shares the same expression profile of miR-23a cluster 
(Figure 10b). Accordingly, also mature miR-23b and miR-27b are expressed in 
undifferentiated cells and decrease until 4 days of SFEB differentiation (Figure 10c). 
Interestingly, BMP4 treatment induces the expression of mature forms of miRNAs 
belonging to miR-23b cluster (Figure 10d). However, 1h of BMP4 treatment does not 
induce the transcription of this cluster, suggesting that BMP4 does not regulate directly 
miR-23b cluster (Figure 10b).  
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Figure 10. Expression levels of miR-23a and miR-23b clusters in ESC neural differentiation 
a) ESCs were differentiated in neuroectodermal precursors using SFEB differentiation method. 
miRNA levels were evaluated in undifferentiated cells, in 2 days SFEBs and 4 days SFEBs by 
qPCR. b) Primary transcripts of miR-23a and miR-23b clusters were measured in ESCs and during 
SFEB differentiation using qPCR. c) miRNAs belonging to miR-23b cluster were measured in 
undifferentiated cells and during SFEB differentiation by qPCR. d) ESCs were stimulated with 
BMP4 for 24h and mature miR-23b and miR-27b were evaluated by qPCR. Data are presented as 
fold change of miRNA levels in undifferentiated (ESCs) and untreated (-BMP4) ESCs (fold change 
= 1). 
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Suppression of miR-23a and miR-23b clusters impairs ESC neural differentiation 
Considering that miRNAs of miR-23a and miR-23b clusters are expressed at high levels in 
undifferentiated cells and they share the targets, so they could compensate each other, we 
decided to study their functions inhibiting them with specific anti-miRs (Figure 11a). We 
first analyzed the effect of their suppression on ESC self-renewal. The analysis of stemness 
markers Oct3/4, Nanog, Rex1 and Dax1 by Q-PCR and Oct3/4 by western blot shows that 
the suppression of miR-23a and miR-23b clusters does not affect ESC self-renewal (Figure 
11b). Then we investigated the effect of inhibition of these two clusters during 
differentiation. To this aim we suppressed miRNAs with specific anti-miRNAs in ESCs 
and then we induced neuroectodermal differentiation through SFEB formation. At 4 days 
of differentiation, SFEBs are composed mainly of cells positive for neuroectodermal 
markers Pax6 and Sox1, but they still retain a few cells positive for stemness markers. 
Upon miRNA suppression we did not find any changes in the expression of 
neuroectodermal markers, but we found a significant decrease in Oct3/4 and Nanog 
expression (Figure 11c).  
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Figure 11. miRNA suppression reduce Oct3/4 and Nanog levels during SFEB differentiation. 
a) ESCs were transfected with specific anti-miRNAs and, after 24h,  miRNA supression was 
evaluated by qPCR. b) In ESCs, miR-23a and miR-23b clusters were suppressed by transfection of 
specific anti-miRNAs. Stemness markers were evaluated after 24h from anti-miRNA transfection 
by qPCR (left panel) and by western blot (right panel). c) ESCs were transfected with anti-miRNAs 
of miR-23a and miR-23b clusters and then induced to differentiate as SFEBs. At 4 days of SFEB 
differentiation stemness markers (Oct3/4 and Nanog) and neuroectoderm markers (Pax6 and Sox1) 
were measured by qPCR (left panel). These markers were also analyzed by western blot (right 
panel) at 2 days and 4 days of SFEB differentiation. Data are presented as fold change over control 
(anti-miR-ctrl) ESCs (fold change = 1). Numbers over the bars indicate the P-Value. 
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Impaired differentiation of miRNA KD ESCs is not due to single miRNA or to altered 
proliferation rate of these cells 
Considering that in our experiments we transfected all miRNAs of miR-23a and miR-23b 
clusters, we wondered whether impaired differentiation of miRNA KD cells could be due 
to the effect of single miRNA KD. Therefore, we transfected single miRNAs in ESCs and 
then we induced SFEB differentiation. In these condition we did not find any changes 
neither in the expression of stemness markers nor in the expression of neuroectodermal 
markers in ESCs and at 4 days of SFEB differentiation (Figure 12a). 
Moreover, to examine whether rapid decrease of stemness markers upon suppression of the 
two clusters could be due to an altered proliferation rate of pluripotent cells, we performed 
a BrdU assay. As shown in Figure 12b, the inhibition of these two clusters does not impair 
ESC proliferation. 
 
Figure 12. Single miRNAs do not impair stemness and differentiation of ESCs and miRNA 
clusters do not alter ESC proliferation rate.  
a) Single anti-miRNA belonging to  miR-23a and miR-23b clusters were transfected in ESCs and 
then cells were induced to differentiate. Left panel shows expression of stemness markers in 
undifferentiated cells, right panel shows stemness and neuroectoderm markers at 4 days of SFEB 
differentiation. Data are expressed as fold change relative to control (anti-miR-ctrl) cells (fold 
change = 1). b) ESCs were transfected with anti-miR-clusters and after 24h BrdU was added to 
culture medium for 1h. ESC proliferation rate was analyzed by immunofluorescence with anti-
BrdU antibody (right panel). Percentage of BrdU positive cells is reported in graph (left panel).  
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The suppression of miR-23a and miR-23b clusters increases apoptosis during ESC 
differentiation 
To better examine the composition of SFEBs derived from ESCs transfected with specific 
anti-miRNAs for miR-23a and miR-23b clusters, we performed immunostaining on 
sectioned SFEBs. We found that in normal conditions 4 days differentiated SFEBs contain 
mainly Sox1-positive cells surrounding groups of Oct3/4-positive cells located in the 
centre of the cell aggregate. Interestingly, in SFEBs derived from miRNA KD ESCs we 
found a  great reduction or absence of Oct3/4-positive cells along with extensive cell death 
in the centre of SFEBs (Figure 13a). These results suggested that the reduced expression of 
Oct3/4 in miRNA KD ESCs could be due to an induced apoptosis upon the miRNA 
suppression.  
To investigate apoptotic phenotype given by miRNA suppression, we analyzed the 
activation of Caspase 3, an hallmark of apoptosis, in ESCs differentiated into 
neuroectoderm precursors. During SFEB differentiation only a small number of cells 
undergoes apoptosis, whereas upon miRNA suppression, about 10% of SFEBs showed a 
widespread presence of Cleaved Caspase 3 positive cells mainly in the centre of EBs 
surrounded by Sox1-positive cells (Figure 13b). The apoptotic effect due to miR-23a and 
miR-23b cluster suppression was also supported by the increased activation of PARP, that 
is cleaved in apoptotic cells (Figure 13c). To further characterize apoptotic phenotype 
given by miRNA suppression, we performed FACS analysis using propidium iodide (PI). 
This assay is widely used for the evaluation of apoptosis because apoptotic cells are 
characterized by DNA fragmentation and, as a consequence, hypodiploidy. PI, a 
fluorochrome capable of binding and labeling DNA, allows the identification of 
hypodiploid cells. Using FACS, we found an increased percentage of hypodiploid cells in 
SFEBs derived from miRNA KD ESCs (Figure 13d). Taken together, these results indicate 
that miRNAs of the 23a and 23b clusters protect ESCs from apoptosis during 
differentiation.   
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Figure 13. Suppression of miR-23a and miR-23b clusters results in apoptosis during SFEB 
differentiation  
a) ESCs transfected with anti-miR-clusters were differentiated as SFEBs. At 4 days of 
differentiation, SFEBs were immunostained to detect stemness (Oct3/4) and neuroectoderm (Sox1) 
markers. Scale bars: 100 µm. Right panel shows a magnification of a representative SFEB. The 
white arrow indicate apoptotic area. Scale bars: 50 µm. b) 4 day differentiated SFEBs derived from 
miRNA KD ESCs were immunostained with apoptotic (Cleaved Caspase 3), stemness (Oct3/4) and 
neuroectoderm (Sox1) markers. Scale bars: 100 µm. The graph reports the percentage of SFEBs 
showing extensive apoptotic area. c) The apoptotic marker Cleaved Parp is measured by western 
blot analysis in 4 day differentiated SFEBs derived from miRNA KD ESCs. d) ESCs were 
tranfected with anti-miR-clusters and then induced to differentiate until 4 days of SFEB 
differentiation. SFEBs were stained with PI and percentage of hypodiploid PI-positive cells was 
measured by FACS analysis (n=6). Numbers over the bars indicate the P-Value.  
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Apoptosis starts after ESC to EpiSC transition during ESC differentiation 
To investigate when apoptosis was triggered, we suppressed miRNAs in ESCs and 
evaluated apoptosis markers in undifferentiated state without finding any alteration in 
miRNA KD ESCs (Figure 14a). Then, we suppressed miRNAs in ESCs and analyzed the 
transition from ESCs to EpiSCs upon miRNAs suppression. As expected, in EpiSCs we 
found decreased levels of stemness marker Dax1, maintenance of Nanog and increased 
expression of the epiblast markers Fgf5, Otx2 and Dnmt3b (Figure 14b). In these 
conditions we did not find any alteration of Cleaved Caspase 3 expression upon miRNA 
KD, suggesting that the apoptotic event starts after the transition from ESCs to EpiSCs 
(Figure 14c).  
 
Figure 14. miR-23a and miR-23b cluster suppression do not impair ESC-EpiSC transition 
a) ESCs were transfected with the indicated anti-miRNAs. Cleaved Caspase 3 was detected by 
immunostaining of undifferentiated cells after 24h from transfection (left panel) and by western 
blot after 24h and 48h from transfection (right panel). Scale bars: 100 µm. b) miR-23a and miR-
23b clusters were suppressed in ESCs and EpiSC differentiation was induced. Stemness (Dax1 and 
Nanog) and epiblast (Fgf5, Dnmt3b, Otx2) markers were detected by qPCR in ESCs and EpiSCs. 
Data are presented as fold change relative to Fgf5 mRNA levels in control (anti-miR-ctrl) ESCs 
(fold change = 1). c) Indicated miRNAs were suppressed in ESCs and epiblast differentiation was 
induced. After 2 days of epiblast differentiation the presence of apoptotic cells was highlighted by 
staining with anti-Cleaved Caspase 3 antibody. Scale bars: 100 µm.  
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Thus, we investigated apoptotic events at 2 and 3 days of SFEB differentiation, when ESC 
to EpiSC transition is overcome. We found increased levels of Cleaved Caspase 3 upon 
miRNA KD already at 2 days of SFEB differentiation (Figure 15a). Also immunostaining 
analysis showed clumps of apoptotic cells in 2 day differentiated SFEBs, with a further 
increase of Cleaved Caspase 3 expression in the next 2 days (Figure 15b). To demonstrate 
that the apoptotic phenotype given by miRNA suppression during differentiation is not 
linked to specific differentiation conditions, we induced ESC differentiation with a 
methods that lead to a more homogenous population of neural precursors. This method 
consists in culturing ESCs as monolayer in presence of N2 and B27 supplements and in 
absence of serum and LIF. We used Sox1-GFP cells (kindly provided by A. Smith) that 
express the gene reporter Enhanced Green Fluorescent Protein (EGFP) under the control of 
Sox1 promoter, which is a specific marker of neuronal precursors. Also with this 
differentiation method, we found a significant percentage of GFP-positive cells undergoing 
apoptosis upon miRNA cluster suppression (Figure 15c). These results suggest that the 
proper levels of miR-23a and miR-23b clusters are required to balance apoptosis and 
survival of ESCs during neuroectodermal differentiation.  
 
Figure 15. Apoptotic phenotype occurs after 2 days of SFEB differentiation 
a) SFEBs were derived from miRNA KD ESCs and activation of Caspase 3 was detected by 
western blot in undifferentiated cells, 2 days and 3 days SFEBs. b) Cleaved Caspase 3 was detect 
by immunostaining of 2days and 3days SFEBs obtained from ESCs transfected with specific anti-
miRNAs. c) Sox1-GFP cells were transfected with anti-miRNAs and differentiated into 
neuroectoderm precursors using monolayer protocol. Differentiated cells were stained with 
Annexin V. Annexin V positive cells were detected by FACS analysis and the percentage of 
positive cells is shown in the graph (n=3).   
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miR-23a and miR-23b clusters protect ESCs from apoptosis  
To investigate whether these miRNAs have a more general effect to protect 
undifferentiated cells from apoptosis, we exposed ESCs to an apoptotic stimulus and 
evaluated the extent of apoptosis upon miRNA suppression. We transfected ESCs with 
specific anti-miRs and exposed these cells to 5 Gy of X rays.  Cleaved Caspase 3 was 
undetectable by western blot in ESCs, whereas the exposure of ESCs to 5 Gy of  X rays 
induced a slight activation of Caspase 3. The suppression of miRNAs in presence of an 
apoptotic stimulus resulted in a strong induction of apoptosis. All these results suggest an 
anti-apoptotic function of these miRNAs also in undifferentiated ESCs (Figure 16).  
 
Figure 16. miR-23a and miR-23 clusters have anti-apoptotic function in ESCs 
ESCs were transfected with indicated miRNAs and after 24h they were irradiated or not with 5Gy 
of X Rays. After 24h Cleaved Caspase 3 was detected by Wester blot analysis.  
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Suppression of miR-23a and miR-23b clusters mimics the treatment with low doses of 
BMP4 
BMP4 signaling may have different effects on ESC differentiation also depending by the 
intensity of the signal. Indeed, high doses of BMP4 (10ng/ml) block ESC differentiation 
(Zhang et al., 2010), whereas low doses of BMP4 induce apoptosis of neural precursor 
cells during epidermal differentiation of ESCs (Gambaro et al., 2006). Accordingly, we 
have found that high doses of BMP4 block differentiation of ESCs toward neuroectoderm, 
whereas low doses of BMP4 activate Caspase 3 thus inducing apoptosis (Figure 17a-b).  
 
Figure 17. Different doses of BMP4 have different effects on ESC differentiation 
a) ESCs were treated with indicated doses of BMP4 and differentiated as SFEBs. Cleaved Caspase 
3 was detected by western Blot. Of note, high doses of BMP4 (10ng/ml) block differentiation, as 
indicated by the strong expression of stemness marker Oct3/4, resulting in reduction of pro-
Caspase-3 expression. The graph reports densitometric analysis of Cleaved Caspase 3 compared to 
pro-Caspase 3. b) Stemness (Oct3/4 and Nanog) and neuroectoderm (Pax6) markers were 
measured by qPCR in 4 days SFEBs derived from ESCs stimulated with different doses of BMP4. 
Data are presented as fold change over untreated (NT) ESCs. Numbers over the bars indicate the P-
Value. 
 
Considering that we have found an apoptotic phenotype upon suppression of miR-23a and 
miR-23b clusters, we reasoned that the suppression of miRNAs could reinforce BMP4 
signaling, thus miming the effects of low doses of BMP4. To investigate this possibility, 
we treated miRNA KD ESCs with the BMP4 antagonist Dorsomorphin. Indeed, if 
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apoptosis is due to an enhancement of BMP4 signaling, the block of BMP4 receptor should 
rescue the apoptotic phenotype. As shown in Figure 18, we have found that Cleaved 
Caspase 3 levels were reduced upon the contemporary suppression of miRNAs and BMP4 
receptor, demonstrating that the apoptotic phenotype observed after miRNA suppression is 
due to a reinforcement of BMP4 signaling during differentiation. 
To demonstrate that the rescue of apoptotic phenotype during differentiation is not linked 
to specific differentiation conditions, we differentiated Sox1-GFP cells with monolayer 
protocol and inhibited BMP4 and miRNAs. We found that also in these differentiation 
conditions apoptotic phenotype given by miRNA suppression was rescued by BMP4 
signaling inhibition (Figure 19a). 
Moreover, to further demonstrate that the apoptotic phenotype due to the suppression of 
miR-23a and miR-23b clusters is mediated by BMP4, we blocked BMP4 signaling at 
intracellular level by silencing Smad1 and Smad5, the two BMP4 effectors highly 
expressed in ESCs. Also in these experimental conditions, we found that the contemporary 
silencing of the miRNAs and Smads reverted the apoptotic phenotype (Figure 19b).  
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Figure 18. BMP4 inhibition rescues apoptotic phenotype given by suppression of miR-23a 
and miR-23b clusters 
ESCs were transfected with indicated anti-miRNAs and treated with BMP4 inhibitor 
(Dorsomorphin) or DMSO as control. After 4 days of SFEB differentiation, activation of Caspase 3 
was evaluated by western blot (upper-left panel) and by immunostaining analysis (lower panel). 
Proper SFEB differentiation was evaluated by immunostaining with stemness (Oct3/4) and 
neuroectoderm (Sox1) markers. Percentage of SFEBs containing diffused apoptotic areas is 
reported in the upper-right panel that shows a strong rescue of apoptotic phenotype upon 
Dorsomorphin treatment. Numbers over the bars indicate the P-Value.  
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Figure 19. Both block of BMP4 receptor and BMP4 effectors rescues apoptosis induced by 
miRNA suppression. 
a) Sox1-GFP cells were transfected with indicated anti-miRNAs, treated with Dorsomorphin and 
differentiated into neuroectoderm precursors using the monolayer protocol. After 4 days of 
differentiation, cells were stained with Annexin V and positive cells were counted by FACS 
analysis. Percentage of Annexin V positive cells were reported in graph (right panel). b) miR-23a 
and miR-23b clusters were suppressed with specific anti-miRNAs and Smad1 and Smad5 were 
silenced with specific siRNAs in ESCs. After 4 days of differentiation, SFEBs were stained with PI 
and PI-positive cells were analyzed by FACS analysis. Right panel shows percentage of 
hypodiploid cells. Numbers over the bars indicate the P-Value. 
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Smad 5 is a direct target of miR-23a and miR-23b clusters 
In order to understand how the suppression of miR-23a and miR-23b clusters enhances 
BMP4 signaling, we searched for miRNA targets involved in BMP4 signaling pathway. 
Using bioinformatic tools, such as miRWalk and Targetscan, we have found several Smads 
among the predicted targets. Moreover, Rogler and co-workers have demonstrated that 
miR-23b cluster targets Smad3, Smad4 and Smad5 in liver stem cells (Rogler et al., 2009). 
To investigate whether our miRNAs could target Smads also in ESCs, we first examined 
the expression of Smads in these cells. We found that Smad3 is not expressed in ESCs and 
during the early steps of differentiation, whereas Smad4 and Smad5 were expressed in 
ESCs and their expression increased during differentiation (Figure 20a). Interestingly, we 
have already demonstrated that miRNA expression decreases during differentiation 
showing an expression profile opposite to that of Smads (Figure 10a,c). Thus, to 
investigate the possible regulation of Smad4 and Smad5 by miR-23a and mR-23b cluster, 
we inhibited miRNAs and measured Smad protein levels. We found that Smad4 protein 
levels were not impaired by miRNA suppression, whereas Smad5 accumulated upon 
miRNA down-regulation, demonstrating that miR-23a and miR-23b clusters regulate 
Smad5 expression in ESCs (Figure 20b). 
 
Figure 20. miR-23a and miR-23b clusters target Smad5  
a) ESCs were differentiated as SFEBs and Smad mRNA levels were measured in undifferentiated 
cells (ESCs), 2 days (2d) and 4 days (4d) of SFEB differentiation. Data are presented as fold 
change relative to Smad3 mRNA level in undifferentiated cells (fold change = 1). b) ESCs were 
transfected with indicated anti-miRNAs  and Smad4 and Smad5 protein levels were measured by 
western blot analysis. Numbers over the bars indicate the P-Value. 
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BMP4, miR-23a cluster and Smad5 generate a feedback loop regulating apoptosis 
during ESC neural differentiation 
We have found that BMP4 controls the transcription of miR-23a cluster, that in turn 
regulates the expression levels of Smad5, finally maintaining the balance between 
apoptosis and survival during ESC differentiation. Considering these findings, we 
speculated that the transcription of miR-23a cluster is induced by BMP4 only when this 
signaling is strong enough to drive its transcriptional activation. Therefore, we measured 
the levels of pri-miRNA transcripts upon different doses of BMP4. We have found that 
only high doses of BMP4 induced the transcription of miR-23a cluster, the same doses that 
block differentiation of ESCs without inducing a significant apoptosis (Figure 21a). 
Moreover, we investigated the behavior of Smad5 in ESCs treated with different doses of 
BMP4. We did not find any changes in mRNA levels of Smad5 after BMP4 treatment 
(Figure 21b), whereas we found reduced Smad5 protein levels in ESCs treated with high 
doses of BMP4, thus showing an opposite trend compared with those of the miRNAs 
(Figure 21c). 
 
Figure 21. High doses of BMP4 induce miR-23a transcription and Smad5 post-
transcriptional regulation 
a) pri-miRNA levels of miR-23a and miR-23b clusters were measured in ESCs treated with 
indicated doses of BMP4. After 1h of BMP4 treatment, pri-miRNA levels were measured by 
qPCR.. b) Smad5 mRNA levels were measured in ESCs treated with indicated doses of BMP4 
using qPCR. Data are shown as fold change relative to untreated cells (fold change = 1). c) Protein 
levels of Smad5 were measured in ESCs upon treatment with indicated doses of BMP4. Numbers 
over the bars indicate the P-Value.  
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Taken together these results demonstrate the existence of a feedback loop controlling the 
balance between apoptosis and survival: a strong stimulation of BMP4 induces the 
transcription of miR-23a cluster that targets Smad5. The reduction of Smad5 protein levels 
down-regulates the response of the cells to BMP4, resulting in the protection from 
apoptosis induced by BMP4 during ESC neuronal differentiation (Figure 23).  
 
Figure 22. BMP4 and miR-23a cluster generate a feedback loop regulating apoptosis in ESC 
differentiation.  
In ESCs, BMP4 regulates several processes such as differentiation, self-renewal and apoptosis 
through Smads activation. Moreover BMP4 induces the transcription of miR-23a cluster, that in 
turn targets Smad5. Smad5 suppression results in a reduced sensibility of the cells to BMP4. As a 
consequence, these miRNAs protect differentiated ESCs from apoptosis induced by BMP4. This 
effect could be also due to the direct targeting of pro-apoptotic genes by miRNAs.  
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DISCUSSION 
 
Many papers have demonstrated that BMP4 has multiple and different roles in ESCs and 
during their differentiation. First, BMP4 contributes to maintain the undifferentiated 
phenotype of ESCs, mostly by blocking the transition from ESCs to EpiSCs (Zhang et al., 
2010). Then, BMP4 is able to drive the differentiation of EpiSCs toward a mesendodermal 
fate by blocking the formation of neuroectoderm (Zhang et al., 2010). Moreover, BMP4 is 
a strong epidermal inducers of neuroectodermal precursors (Kawasaki et al., 2000), indeed 
it interferes with the survival of neural precursors though the induction of their apoptosis 
(Gambaro et al., 2006). However, the molecular mechanisms by which BMP4 fulfills these 
different functions are still poorly understood. We have recently demonstrated that the 
ability of BMP4 to block the transition of ESCs into EpiSCs depends on a feedback loop 
that involves miR-125a. Indeed, BMP4 signaling controls miR-125a expression at 
transcriptional level and in turn this miRNA targets the BMP4 co-receptor Dies1 and such 
regulatory loop sets ESC sensitivity to BMP4 (Parisi et al., 2012). We have hypothesized 
that the interplay between the BMP pathway and miRNAs may represent a more general 
regulatory mechanism modulating the response of ESCs to extracellular stimuli. Starting 
from this idea, we have searched for miRNAs directly regulated by BMP4 and that can 
mediate its function in ESCs. We have analyzed the changes in miRNA expression due to 
BMP4 pathway activation and we have found a miRNA cluster, i.e. miR-23a/miR-24-
2/miR-27a, whose promoter is positively regulated by BMP4 signaling. The miRNAs of 
this cluster are highly expressed in ESCs and their expression, although slightly decreased, 
is maintained during the first phases of differentiation. We have unraveled a crucial 
function of these miRNAs that is the protection of differentiating ESCs from apoptosis. 
Indeed, we have shown that the suppression of these miRNAs leads to a dramatic apoptosis 
increase. Interestingly, we have found that this phenotype can be reverted by blocking 
BMP4 signaling at receptor level by using Dorsomorphin thus indicating that the apoptotic 
effect observed upon miRNA suppression is due to a reinforcement of BMP4 signaling. In 
agreement with these observations we have found that these miRNAs target the BMP4 
effector Smad5. Therefore, we have described the presence of a feedback loop involving 
BMP4 signaling and miRNAs in ESCs. The biological function of this loop is to fine tune 
the sensitivity of ESCs to BMP4 stimuli. Indeed, when the levels of miR-23a cluster are 
normally high, the BMP4 endogenous signaling poorly acts and the differentiation into 
neuroectoderm, accompanied by a physiological apoptosis, can occur. In contrast, a 
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suppression of these miRNAs allows the reinforcement of BMP4 signaling, thanks to the 
accumulation of Smad5, and this in turn results in an aberrant apoptosis during early stage 
of differentiation. As described above, the apoptosis due to miRNA suppression is 
accompanied by a significant decrease of  Oct3/4-positive pluripotent stem cells whereas 
the number of neuroectodermal cells is not affected. The death of pluripotent cells could be 
due to a direct and combined effect of other miRNA targets, beyond Smad5, in these cells 
or can be due to an influence of these miRNAs in lineage determination that we were not 
able to highlight because of the rapid occurrence of apoptosis. Another explanation can be 
the high sensitivity of pluripotent stem cells to the apoptosis that anyway physiologically 
occurs during differentiation. This hypothesis is supported by our observation that 
pluripotent stem cells, in which the miRNAs of the 23a and 23b cluster are suppressed, are 
more sensitive to apoptotic stimuli.   
miR-23a/27a/24-2 is an intergenic miRNA cluster located on the chromosome 8. These 
miRNAs belong to three different families and are not related in sequence. Therefore, their 
control by BMP4 and their targeting of at least one common mRNA (Smad5) suggests a 
coordinate action that the cells can adopt to finely modulate their fate. Other targets of 
these miRNAs have been already described in different biological contexts (Chen et al., 
2014; Cao et al, 2012) and of course, these miRNAs probably control multiple targets in 
addition to Smad5 in ESCs. Nevertheless, the rescue of the apoptotic phenotype obtained 
upon treatment of BMP4 antagonist Dorsomorphin demonstrated that the protective role of 
these miRNAs against apoptosis is mainly due to the targeting of Smad5 that results in a 
reinforcement of BMP4 signaling.  
As mentioned above another cluster located on the chromosome 13 generates a transcript 
containing three miRNAs of the same families, miR-23b/27b/24-1. Also these miRNAs are 
expressed in ESCs and they presumptively control the same targets of miR-23a/27a/24-2. 
We have demonstrated that the suppression of all these miRNAs is necessary to observe 
the apoptotic phenotype due to the reinforcement of BMP4 signaling. However, our results 
indicated that BMP4 directly controls only the cluster of miR-23a/27a/24-2. This 
observation suggests that the BMP4 signaling during ESC differentiation undergoes 
different regulations that are dependent (miRNAs of 23a cluster) or independent (miRNAs 
of 23b cluster) by itself. We have already described a similar control mechanism of BMP4 
pathway by the miRNAs of the 125 family. Indeed, we have demonstrated that  while miR-
125a is directly regulated by BMP4, miR-125b seems to not be regulated by this signaling 
(Parisi et al., 2012; Battista et al., 2013). This multiple controls of extracellular signaling 
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through different miRNAs can probably be due to the relevance of BMP4 in the control of 
the ESC fate, thus indicating that ESCs modulate in different ways a such important 
pathway. 
The anti-apoptotic function of the miRNAs of 23a and 23b cluster in apoptosis was already 
suggested in other biological context by several reports. Indeed, Chen et al. have shown 
that mir-23a/b and miR-27a/b alleviate neuronal apoptosis by suppressing Apaf-1 (Chen et 
al., 2014). In hematopoietic cells exogenous expression of miR-24 induces cell survival 
whereas its suppression  results in an apoptosis increase (Nguyen et al., 2013). On the other 
hand, also BMP4 has been described to have a role in developmentally regulated apoptosis 
(Councouvanis and Martin 1999; Furuta et al., 1997; Gambaro et al., 2006). Although all 
these independent reports indicated a role of both BMP4 and miRNAs of the miR-23a and 
23b clusters in apoptosis, the link between these two actors was not revealed yet. Our 
findings have highlighted this connection by indicating that a low but inappropriate BMP4 
signaling during ESC differentiation trigger apoptosis. This apoptotic signal cannot be 
counteracted by an increase of miRNAs of the-23a cluster because the transcriptional 
activation of this cluster by BMP4 itself occurs only when BMP4 signaling is strongly 
reinforced. On the other hand, when the BMP4 signaling is strong enough it drives the 
accumulation of the miRNAs that can protect from apoptosis and thus, BMP4 signaling 
leads to a differentiation block rather than to cell death. Finally, our results described a 
new loop involving BMP4 and miRNAs. ESCs employ this loop to adapt their response to 
BMP4 signaling on the basis of the strength of this morphogenetic signal. 
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MATERIALS AND METHODS  
 
Cell culture, transfection and treatment 
E14Tg2a (BayGenomics, San Francisco, CA, USA) mouse ESCs and Sox1-GFP ESCs25 
were maintained onfeeder-free, gelatin-coated plates in the following medium: Glasgow 
MinimumEssential Medium (GMEM, Sigma, St. Louis, MO, USA) supplemented with 2 
mMglutamine, 1 mM sodium pyruvate, 1X non-essential amino acids (all fromInvitrogen, 
Carlsbad, CA, USA), 0.1 mM β-mercaptoethanol (Sigma), 10% FBS(Hyclone 
Laboratories, Logan, UT, USA) and 103 U/ml Leukemia Inhibitory Factor(LIF, Millipore, 
Billerica, MA, USA).Transfection of plasmids and anti-miRs (Applied Biosystems, Foster 
City, CA, USA)was performed by plating 6x104cells/cm2 16 h before transfection and 
usingLipofectamine2000 (Invitrogen) following the manufacturer’s instructions.For BMP4 
treatment, ESCs were grown overnight in 10% Knock-out SerumReplacement (KSR, 
Invitrogen) containing medium with LIF and then treated withBMP4 (R&D Systems, 
Minneapolis, MN, USA) at the doses and for the time indicated.For apoptosis induction, 
ESCs were irradiated with 5 Gy of X rays by usingRS2000 Biological Irradiator (Rad 
Source) and incubated for 24 h before the analysis. 
 
Differentiation of ESCs and generation of EpiSCs 
ESC differentiationinto neuroectoderm was induced though SFEB formation.2,20 SFEBs 
wereinduced by placing 1x106 ESCs in 100-mm Petri dishes in the 
followingdifferentiation medium: GMEM supplemented with 2 mM glutamine, 1 mM 
sodiumpyruvate, 1 × nonessential amino acids, 0.1 mM β-mercaptoethanol and 10% 
KSR.Alternatively, the differentiation of Sox1-GFP ESCs25 into neural precursors 
wasdriven by plating 3x103 cells/cm2 on gelatin-coated dishes in differentiation mediumas 
previously described.24BMP4 (at the indicated doses) was added once in the 
differentiation medium whenthe cells were plated in Petri dishes to induce SFEB 
formation. Dorsomorphin (Sigma)was added at 2 μM to differentiating cells and DMSO 
was used as negative control.The formation of EpiSCs was induced adapting the methods 
of Hayashi et al.22 andNakaki et al. 23 In brief, ESCs were dissociated into a single-cell 
suspension with 0.05%Trypsin-EDTA at 37 °C for 5 min. Individual cells were then 
seeded in fibronectin-coateddishes at a density of 2.5x105cells/cm2 in ESC culture 
condition, and after 18 h themedium was switched to the following EpiSC medium: 1 vol 
of DMEM/F12 combined with1 vol of Neurobasal medium, supplemented with 0.5% N2 
43 
 
supplement, 1% B27supplement, 1% KSR, 2 mM glutamine (Invitrogen), 20 ng/ml Activin 
A (R&D Systems),and 12 ng/ml bFGF (Invitrogen). Within 2 days in these conditions the 
cells undergomorphological transformation (including flattening, diminished cell-cell 
interactions andformation of cellular protrusions) and express epiblast markers. 
 
RNA isolation, miRNA profiling and quantitative real-time PCR (qPCR) 
For quantitative PCR total RNA was extracted by using TRI-Reagent(Sigma). The first-
strand cDNA was synthesized according to the manufacturer’sinstructions (M-MLV RT, 
New England BioLabs, Ipswich, MA, USA). qPCR wascarried out with the 7500 Real-
Time PCR System instrument and the SequenceDetection Systems (SDS) 1.4 software 
(Applied Biosystems) using Power SYBRGreen PCR Master mix (Applied Biosystems). 
The housekeeping GAPDH mRNAwas used as an internal standard for normalization, 
using 2-ΔΔCt method. Genespecificprimers used for amplification are listed in 
Supplementary Table S2. For theanalysis of single miRNA sequence specific LNA primers 
were used for theindicated miRNAs or U6 as internal control (both from Exiqon, Vedbaek, 
Denmark).For miRNA profiling, small RNA was isolated from ESCs treated or not with 
BMP4with mirVana miRNA Isolation kit (Ambion, Austin, TX, USA). From each 
sample,40 ng of total RNA was used to synthesize single-stranded cDNA with 
UniversalcDNA Synthesis Kit (Exiqon). Expression level of all miRNAs of Sanger 
miRBasev17 database was measured by using Mouse&Rat Panel microRNA Ready-to-
UsePCR (Exiqon) with the 7900HT instrument and the Sequence Detection Systems(SDS) 
v2.1 software (Applied Biosystems) using SYBR Green Master Mix (Exiqon).The miRNA 
profiling data were analyzed performing a comparative analysis byusing the comparative 
Ct method (2-ΔΔCt, RQManager 1.2 software; AppliedBiosystems) using U6 as 
normalizer. 
 
Antibodies and western blot analysis 
Undifferentiated and differentiatedESCs were lysed in a buffer containing 1 mM EDTA, 
50 mM Tris-HCl (pH 7.5), 70mMNaCl, 1% Triton and protease inhibitor cocktail (Sigma), 
and analyzed by western blot. The following primary antibodies were used: rabbit Smad5 
(1 : 1000Cell Signaling, Danvers, MA, USA), mouse Oct3/4 (1 : 2000 Santa 
CruzBiotechnology, Santa Cruz, CA, USA), rabbit Nanog (1 : 1000 Calbiochem-
EMDBiosciences, La Jolla, CA, USA) mouse GAPDH (1 : 1000 Santa Cruz 
Biotechnology), goat Sox1 (1 : 100 Santa Cruz Biotechnology), rabbit CleavedCaspase-3 
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(1 : 1000 Cell Signaling), rabbit pro-Caspase-3 (1 : 1000 Millipore), rabbitanti-Parp (1 : 
400 Abcam), rabbit phospho-Smad1/5/8 (1 : 1000 Cell Signaling),rabbit Smad1 (1 : 1000 
Cell Signaling), rabbit Smad4 (1 : 1000 GeneTex, Irvine, CA,USA). Antibody protein 
complexes were detected by HRP-conjugated antibodiesand ECL (both from Amersham 
Pharmacia, Milan, Italy). 
 
Chromatin immunoprecipitation (ChIP)-qPCR analysis 
For ChIPqPCRanalysis, ESCs were treated with 20 ng/ml BMP4 for 1 h and then 
werecross-linked with 1% formaldehyde for 10 min at room temperature and then with125 
mM glycine. The chromatin was then sonicated to an average DNA fragmentlength of 
500–1000 bp. Soluble chromatin extracts were immunoprecipitated usingan anti-Phospho-
Smad1,5,8 (Cell Signaling) antibody. Appropriate IgGs were usedas negative control. 
Supernatant obtained without an antibody was used as an inputcontrol. After qPCR, the 
amount of precipitated DNA was calculated relatively to thetotal input chromatin and 
expressed as percentage of total chromatin or as foldenrichment relative to untreated 
samples. Oligonucleotide pairs are listed inSupplementary Table S1. 
 
FACS analysis 
Analysis of DNA content by propidium iodide incorporation was performed in 
permeabilized cells by flow cytometry. SFEBs at 4 days ofdifferentiation were dissociated 
and 2 × 104 cells were collected, washed in PBSand resuspended in 200 μl of a solution 
containing 0.1% sodium citrate w/v, 0.1%Triton X-100 v/v and 50 μg/ml propidium iodide 
(Sigma Chemical, Perth, WA,Australia). After incubation at 4 °C for 30 min in the dark, 
cell nuclei were analyzedwith a FACScan flow cytometer (Becton Dickinson, Milan, 
Italy). Cellular debris wasexcluded from the analysis by raising the forward scatter 
threshold, and the DNAcontent of the nuclei was registered on a logarithmic scale. The 
percentage of theelements in the hypodiploid region was calculated.Phosphatidylserine 
externalization was investigated by annexin V staining. In brief,SFEBs at 4 days of 
differentiation were dissociated and 1 × 105 cells were collectedand resuspended in 100 μl 
of binding buffer (10 mM Hepes/NaOH pH 7.5, 140 mMNaCl, and 2.5 mM CaCl2) 
containing 5 μl of annexin V-FITC (Pharmingen/BectonDickinson, San Diego, CA, USA) 
for 15 min at room temperature in the dark. Then,400 μl of the same buffer was added to 
each sample and the cells were analyzed witha Becton Dickinson FACScan flow 
cytometer. 
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Immunostaining, bromodeoxyuridine assay and microscopy 
Undifferentiated ESCs and EpiSCs were fixed in 4% paraformaldehyde andpermeabilized 
with 0.2% Triton X-100 in 10% FBS (Invitrogen)/1% BSA in 1X PBSfor 150 at room 
temperature. Thus, the samples were incubated with primaryantibodies and with an 
appropriate secondary antibody reported below. SFEBs werecollected at the indicated 
differentiation day fixed in 4% paraformaldehyde anddehydrated with increasing 
percentages of ethanol. Samples were embedded inparaffin, sectioned in 7-μm slices and 
mounted on glass slides. After rehydrationand permeabilization, the samples were treated 
as previously described.20 Nucleiwere counterstained with DAPI (Calbiochem, 1 : 1000) 
or, for confocal analysis, withDRQ5 (Cell Signaling, 1 : 1000) as indicated in the Figures. 
The following primaryantibodies were used: anti-Oct3/4 (1 : 200), anti-Nanog (1 : 500; 
Calbiochem), anti-Sox1 (1 : 100) and anti-cleaved caspase 3 (1 : 300). Alexa Fluor 594 
or488 secondary antibodies were used (1 : 400; Invitrogen). For BrdU 
experiments,subconfluent ESCs were incubated in ESC medium containing BrdU for 1 h, 
andthen the cells were processed for immunofluorescence with BrdU labeling anddetection 
kit (Roche, Basel, Switzerland). Images were captured with an invertedmicroscope 
(DMI4000; Leica Microsystems, Heidelberg, Germany) with LeicaApplication Suite 
Advanced Fluorescence (LAS AF) software (Leica Microsystems).Confocal microscopy 
was performed with a Leica TCSSMD FLIM microscope (LeicaMicrosystems) using LAS 
AF software (Leica Microsystems). When required, thebrightness, contrast and color 
balance of the images were adjusted in PhotoshopCS2 (Adobe Systems, San Jose, CA, 
USA). 
 
Statistical analysis 
All values represent the means±S.E. of at least threeindependent experiments. qPCR data 
are presented as fold change relative to theindicated reference sample. Whenever 
necessary, statistical significance of the datawas analyzed using Student’s t -test and the P-
Value was reported in the figures. 
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Nameᵃ Forward primer Reverse primer  
miR-125a  GTTTCTGTCTCGCTTCCCCGTTC CAAATGATGGTCAAGCATCAGG 
miR-142 GTCCCTGGGAAGTTACACGG GATTCTTCAGGCCACCTGCT 
miR-187 CTGGGTACACAGCAGATGGG TATCCTGTGAGCCCAGGGAG 
miR-193b CTGTCTCTAGGGCAAGGCTG TCTCTGAAGTGAGCCCCTCT 
miR-196a-1 TGGTTAACTAGCAGCGGACC GTGAGCTAAAATGGCCACGC 
miR-196a-2 TCCTCAGGGAGGTTGTAGGG GGGCTTGGGGAAGGAAGAAA 
miR-199a AGAAGAGTTCAGGGTGCGTG TGTTCAGTTCCTCAGCGTGG 
miR-211 TAGCCTGAGCCAAGAGCAAG CGTCAGGATCATGGCGACTT 
miR-23a/24-
2/27a ACTGGTGCATTCGGAAACCT GGAGCATTCTTGCTTGCCTG 
miR-23b/24-
1/27b TGGGGGTGTGGTTCTTTGTC ATCATCTTGCCAGCGACTGT 
miR-29b-1 AGTGACCGACATGTCACACC GAGGGAAGGTGAAGTCCGTG 
miR-29b-2 TGTCATCTGCGTCTGACAGG GCAGTCAGAAGAACCAGCCT 
miR-302d GTCTTTCACCCTCCGAGGAC TCCTTTACCTTCGTGACCGC 
miR-324 TTCGAGGCTTCCGACTTTGT GCTAAATGCTGCCCAGATGC 
miR-339 GCCGCATCTGTCATCTTTGTC CCACCTAGGGATCCCCTTCT 
miR-362 CAGAGCGCATCTCTCGTTCT CCCTTCCTGTGTGTGGTCAA 
miR-379 CACCGTGCAACCATTCAAGG TCTGAGGCCTGATTTGGCAG 
miR-503 CTCCTCCCCACTATCCACCA GGATCTGCTGGTGAGGCAAA 
miR-582 ACAAAGGAAGCTCCGCCAAT GCACGGCTTGTGTTTGAGAA 
miR-9-1 TCCCATCTTTTCGCCTCCAC CTCCGTAGTCTCGAGTCGCT 
miR-9-2 GCTTAAACGCGGCAAGTACC CCTTCCTCTGGCTGAACTCC 
miR-9-3 TCCGTGTGTCTGTGTGTCTG GACTCCGCTCCCGCAG 
1 CAACCCTGTAGCGACTCTGG CCGGTATGGGGCCTAGTGTA 
2 TTGGCACTCTGCATCTGAGG ACTCAGGCGTTTACTCAGGC 
3 TTTTGTTCCTGGCCCCCTAC CCCTCCACCATCAGGAACAC 
4 CTTGGCTCCCTGTACCTGTC TTACCTTCTCAGGCCACCCT 
5 GGTGTGTCTTCCTAGCTGGC GCATGATGCTGTCCTTCCCT 
6 GAAGAGTGGGCCATTAGCGA AAGCAGCGAGGATCGGAAAA 
7 TGTGAGCCGGGAAACCAAAT ACAAGTTCAGGGCTGGAAAGA 
8 TGCAGACAGAGACTTTGCCA GTCAGCCTGCATGTGAGCTA 
9 GAGCATCTTGTGGCTTCCCT GCTTGTGTTGTCCCCAGGTA 
10 CACTTGCTGGATCAGCTTGC TGGGGCCTACCCAATGTAGA 
11 ACTGGTGCATTCGGAAACCT GGAGCATTCTTGCTTGCCTG 
Dax1 AGATGGAGAAAGCGGTCGTA AAGCCAGTATGGAGCAGAGG 
Dnmt3b CCAAGGACACCAGGACGCGC TCCGAGACCTGGTAGCCGGAA 
Fgf5 
TCCATGCAAGTGCCAAATTTACGG
A TTCTGTGGATCGCGGACGCA 
Gapdh GTATGACTCCACTCACGGCAAA TTCCCATTCTCGGCCTTG 
Id1 TCCGCCTGTTCTCAGGATCA GTAGCAGCCGTTCATGTCGT 
Id3 CGACATGAACCACTGCTACT CTCCTCTTGTCCTTGGAGAT 
Nanog TCAGAAGGGCTCAGCACCA GCGTTCACCAGATAGCCCTG 
47 
 
Oct3/4 AACCTTCAGGAGATATGCAAATCG TTCTCAATGCTAGTTCGCTTTCTCT 
Otx2 TTCCGTCACTCCAAATCTACCCA 
GCCGGACGGTCTCGATTCGCCTGGAG
T 
Pax6 AGTGAATGGGCGGAGTTATG ACTTGGACGGGAACTGACAC 
Rex1 GCAGTTTCTTCTTGGGATTTCAG CTAATGCCCACAGCGAT 
Smad3 CTCCAAACCTCTCCCCGAAT GACTGGCTGTAGGTCCAAGT 
Smad4 CCACAGGACAGAAGCGATTG ACTAAGGCACCTGACCCAAA 
Smad5 AGGAACCTGAGCCACAATGA GAAAGGAGCGTTGTTGGGTT 
ᵃThe primer name is reported as indicated in the Figures. 
  
Table 2. Primers used for Real-Time PCR 
 
  
48 
 
REFERENCES 
 
Akerblom M, Jakobsson J. "MicroRNAs as Neuronal Fate Determinants" Neuroscientist. 
 2013; 20(3):235-242. 
Avilion AA, Nicolis SK, Pevny LH, Perez L, Vivian N, Lovell-Badge R. "Multipotent cell 
 lineages in early mouse development depend on SOX2 function" Genes Dev. 2003; 
 17(1):126-40. 
Bartel DP. "MicroRNAs: genomics, biogenesis, mechanism, and function" Cell. 2004; 
 116(2):281-97. 
Battista M, Musto A, Navarra A, Minopoli G, Russo T, Parisi S. "miR-125b Regulates the 
 Early Steps of ESC Differentiation through Dies1 in a TGF-Independent Manner" 
 Int J Mol Sci. 2013; 14(7):13482-96. 
Beddington RS, Robertson EJ. "An assessment of the developmental potential of 
 embryonic stem cells in the midgestation mouse embryo" Development. 1989; 
 105(4):733-7. 
Bibel M, Richter J, Schrenk K, Tucker KL, Staiger V, Korte M, Goetz M, Barde YA. 
 "Differentiation of mouse embryonic stem cells into a defined neuronal lineage" 
 Nat Neurosci. 2004; 7(9):1003-9. 
Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar 
 RM, Murray HL, Jenner RG, Gifford DK, Melton DA, Jaenisch R, Young RA. 
 "Core transcriptional regulatory circuitry in human embryonic stem cells" Cell. 
 2005; 122(6):947-56. 
Brons IG, Smithers LE, Trotter MW, Rugg-Gunn P, Sun B, Chuva de Sousa Lopes SM, 
 Howlett SK, Clarkson A, Ahrlund-Richter L, Pedersen RA, Vallier L. "Derivation 
 of pluripotent epiblast stem cells from mammalian embryos" Nature 2007; 
 448(7150):191-5. 
Burdon T, Stracey C, Chambers I, Nichols J, Smith A. "Suppression of SHP-2 and ERK 
 signalling promotes self-renewal of mouse embryonic stem cells" Dev Biol. 1999; 
 210(1):30-43. 
Cao M, Seike M, Soeno C, Mizutani H, Kitamura K, Minegishi Y, Noro R, Yoshimura A, 
 Cai L, Gemma A. "MiR-23a regulates TGF-β-induced epithelial-mesenchymal 
 transition by targeting E-cadherin in lung cancer cells" Int J Oncol. 2012; 
 41(3):869-75. 
49 
 
Chambers I, Colby D, Robertson M, Nichols J, Lee S, Tweedie S, Smith A. "Functional 
 expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem 
 cells" Cell. 2003; 113(5):643-55. 
Chen CZ, Li L, Lodish HF, Bartel DP. "MicroRNAs modulate hematopoietic lineage 
 differentiation" Science. 2004; 303(5654):83-6. 
Chen Q, Xu J, Li L, Li H, Mao S, Zhang F, Zen K, Zhang CY, Zhang Q. "MicroRNA-
 23a/b and microRNA-27a/b suppress Apaf-1 protein and alleviate hypoxia-induced 
 neuronal apoptosis" Cell Death Dis. 2014; 5:e1132.  
Cheng LC, Tavazoie M, Doetsch F. "Stem cells: from epigenetics to microRNAs" Neuron. 
 2005; 46(3):363-7. 
Chew JL, Loh YH, Zhang W, Chen X, Tam WL, Yeap LS, Li P, Ang YS, Lim B, Robson 
 P, Ng HH. "Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the 
 Oct4/Sox2 complex in embryonic stem cells" Mol Cell Biol. 2005; 25(14):6031-46. 
Coucouvanis E, Martin GR. "BMP signaling plays a role in visceral endoderm 
 differentiation and cavitation in the early mouse embryo" Development. 1999; 
 126(3):535-46. 
Delaloy C, Liu L, Lee JA, Su H, Shen F, Yang GY, Young WL, Ivey KN, Gao FB. 
 "MicroRNA-9 coordinates proliferation and migration of human embryonic stem 
 cell-derived neural progenitors" Cell Stem Cell. 2010; 6(4):323-35. 
Derynck R, Zhang YE. "Smad-dependent and Smad-independent pathways in TGF-beta 
 family signalling" Nature. 2003; 425(6958):577-84. 
Fei T, Xia K, Li Z, Zhou B, Zhu S, Chen H, Zhang J, Chen Z, Xiao H, Han JD, Chen YG. 
 "Genome-wide mapping of SMAD target genes reveals the role of BMP signaling 
 in embryonic stem cell fate determination" Genome Res. 2010; 20(1):36-44. 
Furuta Y, Piston DW, Hogan BL. "Bone morphogenetic proteins (BMPs) as regulators of 
 dorsal forebrain development" Development. 1997; 124(11):2203-12. 
Gambaro K, Aberdam E, Virolle T, Aberdam D, Rouleau M. "BMP-4 induces a Smad-
 dependent apoptotic cell death of mouse embryonic stem cell-derived neural 
 precursors" Cell Death Differ. 2006; 13(7):1075-87.  
Gangaraju VK, Lin H. "MicroRNAs: key regulators of stem cells" Nat Rev Mol Cell Biol. 
 2009; 10(2):116-25.  
Gaughwin P, Ciesla M, Yang H, Lim B, Brundin P. "Stage-specific modulation of cortical 
 neuronal development by Mmu-miR-134" Cereb Cortex. 2011; 21(8):1857-69. 
50 
 
Gerrard L, Rodgers L, Cui W. "Differentiation of human embryonic stem cells to neural 
 lineages in adherent culture by blocking bone morphogenetic protein signaling" 
 Stem Cells. 2005; 23(9):1234-41.  
Heo I, Joo C, Cho J, Ha M, Han J, Kim VN. "Lin28 mediates the terminal uridylation of 
 let-7 precursor MicroRNA" Mol Cell. 2008; 32(2):276-84.  
Hollnagel A, Oehlmann V, Heymer J, Rüther U, Nordheim A. "Id genes are direct targets 
 of bone morphogenetic protein induction in embryonic stem cells" J Biol Chem. 
 1999; 274(28):19838-45. 
Houbaviy HB, Murray MF, Sharp PA. "Embryonic stem cell-specific MicroRNAs" Dev 
 Cell. 2003; 5(2):351-8. 
Huang G, Ye S, Zhou X, Liu D, Ying QL. "Molecular basis of embryonic stem cell self-
 renewal: from signaling pathways to pluripotency network" Cell Mol Life Sci. 
 2015.  
Kanellopoulou C, Muljo SA, Kung AL, Ganesan S, Drapkin R, Jenuwein T, Livingston 
 DM, Rajewsky K. "Dicer-deficient mouse embryonic stem cells are defective in 
 differentiation and centromeric silencing" Genes Dev. 2005; 19(4):489-501. 
Kawasaki H, Mizuseki K, Nishikawa S, Kaneko S, Kuwana Y, Nakanishi S, Nishikawa SI, 
 Sasai Y. "Induction of midbrain dopaminergic neurons from ES cells by stromal 
 cell-derived inducing activity" Neuron. 2000; 28(1):31-40. 
Krichevsky AM, Sonntag KC, Isacson O, Kosik KS. "Specific microRNAs modulate 
 embryonic stem cell-derived neurogenesis" Stem Cells. 2006; 24(4):857-64.  
Kuroda T, Tada M, Kubota H, Kimura H, Hatano SY, Suemori H, Nakatsuji N, Tada T. 
 "Octamer and Sox elements are required for transcriptional cis regulation of Nanog 
 gene expression" Mol Cell Biol. 2005; 25(6):2475-85. 
Li X, Jin P. "Roles of small regulatory RNAs in determining neuronal identity" Nat Rev 
 Neurosci. 2010; 11(5):329-38.  
Li Z, Fei T, Zhang J, Zhu G, Wang L, Lu D, Chi X, Teng Y, Hou N, Yang X, Zhang H, 
 Han JD, Chen YG. "BMP4 Signaling Acts via dual-specificity phosphatase 9 to 
 control ERK activity in mouse embryonic stem cells" Cell Stem Cell. 2012; 
 10(2):171-82.  
Liu N, Lu M, Tian X, Han Z. "Molecular mechanisms involved in self-renewal and 
 pluripotency of embryonic stem cells" J Cell Physiol. 2007; 211(2):279-86. 
Lodish HF, Zhou B, Liu G, Chen CZ. "Micromanagement of the immune system by 
 microRNAs" Nat Rev Immunol. 2008 Feb;8(2):120-30. 
51 
 
Makeyev EV, Zhang J, Carrasco MA, Maniatis T. "The MicroRNA miR-124 promotes 
 neuronal differentiation by triggering brain-specific alternative pre-mRNA 
 splicing" Mol Cell. 2007; 27(3):435-48. 
Marson A, Levine SS, Cole MF, Frampton GM, Brambrink T, Johnstone S, Guenther MG, 
 Johnston WK, Wernig M, Newman J, Calabrese JM, Dennis LM, Volkert TL, 
 Gupta S, Love J, Hannett N, Sharp PA, Bartel DP, Jaenisch R, Young RA. 
 "Connecting microRNA genes to the core transcriptional regulatory circuitry of 
 embryonic stem cells" Cell. 2008; 134(3):521-33.  
Matsuda T, Nakamura T, Nakao K, Arai T, Katsuki M, Heike T, Yokota T. "STAT3 
 activation is sufficient to maintain an undifferentiated state of mouse embryonic 
 stem cells" EMBO J. 1999; 18(15):4261-9. 
Melton C, Judson RL, Blelloch R. "Opposing microRNA families regulate self-renewal in 
 mouse embryonic stem cells" Nature. 2010; 463(7281):621-6.  
Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, Maruyama M, 
 Maeda M, Yamanaka S. "The homeoprotein Nanog is required for maintenance of 
 pluripotency in mouse epiblast and ES cells" Cell. 2003; 113(5):631-42. 
Mizuseki K, Sakamoto T, Watanabe K, Muguruma K, Ikeya M, Nishiyama A, Arakawa A, 
 Suemori H, Nakatsuji N, Kawasaki H, Murakami F, Sasai Y. "Generation of neural 
 crest-derived peripheral neurons and floor plate cells from mouse and primate 
 embryonic stem cells" Proc Natl Acad Sci U S A. 2003; 100(10):5828-33.  
Murry CE, Keller G. "Differentiation of embryonic stem cells to clinically relevant 
 populations: lessons from embryonic development" Cell. 2008; 132(4):661-
 80. 
Musto A, Navarra A, Vocca A, Gargiulo A, Minopoli G, Romano S, Romano MF, Russo 
 T, Parisi S. "miR-23a, miR-24 and miR-27a protect differentiating ESCs from 
 BMP4-induced apoptosis" Cell Death Differ. 2014.  
Newman MA, Thomson JM, Hammond SM. "Lin-28 interaction with the Let-7 precursor 
 loop mediates regulated microRNA processing" RNA. 2008; 14(8):1539-49.  
Nguyen T, Rich A, Dahl R. "MiR-24 promotes the survival of hematopoietic cells" PLoS 
 One. 2013;8(1):e55406.  
Niu CS, Yang Y, Cheng CD. "MiR-134 regulates the proliferation and invasion of 
 glioblastoma cells by reducing Nanog expression" Int J Oncol. 2013; 42(5):1533-
 40. 
52 
 
Niwa H, Burdon T, Chambers I, Smith A. "Self-renewal of pluripotent embryonic stem 
 cells is mediated via activation of STAT3" Genes Dev. 1998; 12(13):2048-60. 
Niwa H, Miyazaki J, Smith AG "Quantitative expression of Oct-3/4 defines differentiation, 
 dedifferentiation or self-renewal of ES cells" Nat Genet. 2000; 24(4):372-6. 
Niwa H, Toyooka Y, Shimosato D, Strumpf D, Takahashi K, Yagi R, Rossant J. 
 "Interaction between Oct3/4 and Cdx2 determines trophectoderm differentiation" 
 Cell. 2005; 123(5):917-29. 
Niwa H. "How is pluripotency determined and maintained?" Development. 2007; 
 134(4):635-46. 
Okamura K, Hagen JW, Duan H, Tyler DM, Lai EC. "The mirtron pathway generates 
 microRNA-class regulatory RNAs in Drosophila" Cell. 2007; 130(1):89-100.  
Pan G, Li J, Zhou Y, Zheng H, Pei D. "A negative feedback loop of transcription factors 
 that controls stem cell pluripotency and self-renewal" FASEB J. 2006; 
 20(10):1730-2. 
Parisi S, Battista M, Musto A, Navarra A, Tarantino C, Russo T. "A regulatory loop 
 involving Dies1 and miR-125a controls BMP4 signaling in mouse embryonic stem 
 cells" FASEB J. 2012; 26(10):3957-68.  
Pfister S, Steiner KA, Tam PP. "Gene expression pattern and progression of 
 embryogenesis in the immediate post-implantation period of mouse development" 
 Gene Expr Patterns. 2007; 7(5):558-73.  
Pierce GB, Arechaga J, Muro C, Wells RS. "Differentiation of ICM cells into 
 trophectoderm" Am J Pathol. 1988; 132(2):356-64. 
Qi X, Li TG, Hao J, Hu J, Wang J, Simmons H, Miura S, Mishina Y, Zhao GQ. "BMP4 
 supports self-renewal of embryonic stem cells by inhibiting mitogen-activated 
 protein kinase pathways" Proc Natl Acad Sci U S A. 2004; 101(16):6027-32.  
Rana TM. "Illuminating the silence: understanding the structure and function of small 
 RNAs" Nat Rev Mol Cell Biol. 2007; 8(1):23-36. 
Rodda DJ, Chew JL, Lim LH, Loh YH, Wang B, Ng HH, Robson P. "Transcriptional 
 regulation of nanog by OCT4 and SOX2" J Biol Chem. 2005; 280(26):24731-7.  
Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A. "Identification of mammalian 
 microRNA host genes and transcription units" Genome Res. 2004; 14(10A):1902-
 10. 
Rogler CE, Levoci L, Ader T, Massimi A, Tchaikovskaya T, Norel R, Rogler LE. 
 "MicroRNA-23b cluster microRNAs regulate transforming growth factor-beta/bone 
53 
 
 morphogenetic protein signaling and liver stem cell differentiation by targeting 
 Smads" Hepatology. 2009; 50(2):575-84.  
Rossant J, Chazaud C, Yamanaka Y. "Lineage allocation and asymmetries in the early 
 mouse embryo" Philos Trans R Soc Lond B Biol Sci. 2003; 358(1436):1341-8 
Rybak A, Fuchs H, Smirnova L, Brandt C, Pohl EE, Nitsch R, Wulczyn FG. "A feedback 
 loop comprising lin-28 and let-7 controls pre-let-7 maturation during neural stem-
 cell commitment" Nat Cell Biol. 2008; 10(8):987-93.  
Saunders LR, Sharma AD, Tawney J, Nakagawa M, Okita K, Yamanaka S, Willenbring H, 
 Verdin E. "miRNAs regulate SIRT1 expression during mouse embryonic stem cell 
 differentiation and in adult mouse tissues" Aging (Albany NY). 2010; 2(7):415-31. 
Schmierer B, Hill CS. "TGFbeta-SMAD signal transduction: molecular specificity and 
 functional flexibility" Nat Rev Mol Cell Biol. 2007; 8(12):970-82. 
Shi W, Wang H, Pan G, Geng Y, Guo Y, Pei D. "Regulation of the pluripotency marker 
 Rex-1 by Nanog and Sox2" J Biol Chem. 2006; 281(33):23319-25.  
Sinkkonen L, Hugenschmidt T, Berninger P, Gaidatzis D, Mohn F, Artus-Revel CG, 
 Zavolan M, Svoboda P, Filipowicz W. "MicroRNAs control de novo DNA 
 methylation through regulation of transcriptional repressors in mouse embryonic 
 stem cells" Nat Struct Mol Biol. 2008; 15(3):259-67.  
Smith AG, Heath JK, Donaldson DD, Wong GG, Moreau J, Stahl M, Rogers D. "Inhibition 
 of pluripotential embryonic stem cell differentiation by purified polypeptides" 
 Nature 1988; 336(6200):688-90. 
Tarantino C, Paolella G, Cozzuto L, Minopoli G, Pastore L, Parisi S, Russo T. "miRNA 
 34a, 100, and 137 modulate differentiation of mouse embryonic stem cells" FASEB 
 J. 2010; 24(9):3255-63.  
Tay Y, Zhang J, Thomson AM, Lim B, Rigoutsos I. "MicroRNAs to Nanog, Oct4 and 
 Sox2 coding regions modulate embryonic stem cell differentiation" Nature. 2008; 
 455(7216):1124-8.  
Tesar, P. J., Chenoweth, J. G., Brook, F. A., Davies, T. J., Evans, E. P., Mack, D. L., 
 Gardner, R. L. and McKay, R. D. "New cell lines from mouse epiblast share 
 defining features with human embryonic stem cells" Nature 2007; 448, 196-199. 
Tropepe V, Hitoshi S, Sirard C, Mak TW, Rossant J and van der Kooy D. "Direct neural 
 fate specification from embryonic stem cells: a primitive mammalian neural stem 
 cell stage acquired through a default mechanism" Neuron 2001; 30, 65-78. 
54 
 
Wang Y, Medvid R, Melton C, Jaenisch R, Blelloch R. "DGCR8 is essential for 
 microRNA biogenesis and silencing of embryonic stem cell self-renewal" Nat 
 Genet. 2007; 39(3):380-5.  
Watanabe K, Kamiya D, Nishiyama A, Katayama T, Nozaki S, Kawasaki H, Watanabe Y, 
 Mizuseki K, Sasai Y. "Directed differentiation of telencephalic precursors from 
 embryonic stem cells" Nat Neurosci. 2005; 8(3):288-96. 
Westholm JO, Lai EC. "Mirtrons: microRNA biogenesis via splicing" Biochimie. 2011; 
 93(11):1897-904. 
Wichterle H, Lieberam I, Porter JA, Jessell TM. "Directed differentiation of embryonic 
 stem cells into motor neurons" Cell 2002; 110, 385–397. 
Ying QL, Nichols J, Chambers I and Smith A. "BMP induction of Id proteins suppresses 
 differentiation and sustains embryonic stem cell selfrenewal in collaboration with 
 STAT3" Cell 2003a; 115, 281-292. 
Ying QL, Stavridis M, Griffiths D, Li M, Smith A. "Conversion of embryonic stem cells 
 into neuroectodermal precursors in adherent monoculture" Nat Biotechnol. 2003b; 
 1(2):183-6. 
Zhang K, Li L, Huang C, Shen C, Tan F, Xia C, Liu P, Rossant J, Jing N. "Distinct 
 functions of BMP4 during different stages of mouse ES cell neural commitment" 
 Development. 2010; 137(13):2095-105.  
Zhao C, Sun G, Li S, Lang MF, Yang S, Li W, Shi Y. "MicroRNA let-7b regulates neural 
 stem cell proliferation and differentiation by targeting nuclear receptor TLX 
 signaling" Proc Natl Acad Sci U S A. 2010; 107(5):1876-81.  
 
